Welltower Inc.
WELL · NYSE
Analyst Consensus
Buy
Analyst Ratings Synthesis
The supplied consensus is Buy across 19 analysts, with targets listed at a $255 low, $260.5 mean, and $255 high; the low and high are internally inconsistent, so a reliable spread cannot be calculated from those figures. Other supplied aggregators show materially different ranges, including $208-$260 at TipRanks and $146.45-$252 at Fintel, underscoring disagreement over valuation. The evidence does not identify the most or least bullish analyst. It also provides no rating revisions during the reported week. The only named revision is Citigroup’s May 5 target increase from $245 to $255, while the substantive disagreement centers on demographic-driven cash-flow growth versus a valuation already reflecting that growth.
- Welltower (WELL) Stock May Be Fully Priced On Cash Flow Growth
- Align Technology stock underperforms as shares trade well below analyst targets - ad-hoc-news.de
- WELL Health Technologies Stock Under Pressure as Sentiment Weakens and Correction Risks Rise
- 8,302 Shares in Welltower Inc. $WELL Bought by IPG Investment Advisors LLC
- ‘A well-kept secret’: Station Casinos surprises employees with $70M stock giveaway - Las Vegas Review-Journal
Rating Actions
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Citigroup Inc. | — | $255 | +8.9% | May 5, 2026 | Open the report this row came from | |
| BMO Capital Markets | — | $245 | +4.6% | May 4, 2026 | Open the report this row came from | |
| Citigroup Inc. | — | $275 | +17.4% | May 4, 2026 | Open the report this row came from |
